This CME lecture introduces the learner to the updated consensus guidelines for managing abnormal cervical cancer screening tests and diagnosed cervical cancer precursor lesions, published in March, 2013, by the ASCCP, in the Journal of Lower Genital Tract Diseases. Not only does the presentation include the guidelines, but the rationale for risk based management of abnormalities, and application of the metric of equal management for equal risk of high grade disease. To facilitate understanding of the new guidelines, liberal use of algorithms are used as tools in this presentation.
This two part CME course will increase knowledge regarding the pathogenesis and clinical presentation, and particularly the appearance, of vulvar precancerous lesions. The participant will gain the ability to decide when and how to biopsy these lesions, and to understand the categorization of both HPV-related and non-HPV-related conditions, including the latest Lower Anogenital Squamous Terminology (LAST) nomenclature system. In the second part of the course, the participant will learn about the various management options for precancerous vulvar abnormalities and the potential risks and benefits of each one.
Is this educational activity right for me?
The Online CME lecture "Guidelines for Management of Abnormal Cervical Cancer Screening Tests and Cervical Cancer Precursors” will best serve those physicians and advanced practice clinicians (e.g., nurse practitioners, physician’s assistants, nurse midwives) providing primary cervical cancer screening and management of their women patients. Surveys of prior online courses including this subject demonstrated that both ASCCP members and non-members utilized this online program to gain better understanding of the guidelines and improved uptake of the guidelines in their clinical practices. Therefore, this program is intended for clinicians from a variety of specialties including obstetrics and gynecology, family medicine and, internal medicine, for residents in obstetrics/gynecology and family medicine, for advanced practice clinicians working in family planning and other community clinics, private offices and hospital settings, for pathologists who supervise residents and fellows, and for physicians with administrative responsibility for gynecology patients.
Course Competencies and Objectives
Upon completion of the course, participants will be able to do the following:
-Understand reasons for not screening women under age 21.
-Determine appropriate age-specific, and condition specific management of women with abnormal cervical cancer screening results or cervical cancer precursors.
-Develop skills in counseling colleagues and patients about HPV infection, the purpose and rationale for cervical cytology and HPV screening and the management of, abnormal screening results and diagnosed cancer precursors.
-Share the knowledge gained from this CME course with colleagues to improve adherence to cervical cancer screening and management recommendations.
-Choose the cervical cancer screening and management option, or options, most likely to benefit the patient while minimizing potential opportunity for harms.
The American Society for Colposcopy and Cervical Pathology (ASCCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
Continuing Medical Education (CME) Credit
The ASCCP designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Management of Conflicts of Interest and Contributed Funds
As an accredited provider of CME credit, ASCCP is required to comply with the ACCME's Standards for Commercial Support and has implemented a management process to ensure that anyone who is in a position to affect the content of the educational activity (e.g., faculty, planners, etc.) has disclosed to us all relevant financial relationships with any commercial interest and has ensured that those relationships do not influence presentation materials. All faculty have agreed to base their presentations on best available evidence. ASCCP discloses to learners any financial relationship(s) to healthcare-related commercial interests existing within the past 12 months to include the following information: 1) the name of the individual; 2) the name of the commercial interest; and, 3) the nature of the relationship the person has with each commercial interest. Slides and slide notes are reviewed for possible bias prior to the activity's release by the Accreditation Committee and peer-reviewers, and potential conflicts of interest are resolved prior to the live presentation. Any discussion of off-label use of products is noted when appropriate, as is discussion of any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Disclosures of these commitments and/or relationships are published in these lecture materials and provided prior to the start of the activity, so the learners may formulate their own judgments regarding the presentation(s). Under ASCCP policy, anyone declining either to disclose or amend material to eliminate potential bias identified by the Accreditation Committee will be replaced.
Author, Reviewers, and Planners' Disclosure Information
The following are all reported disclosures of interest or potential conflicts from the 12 months preceding this activity.
Those reporting no financial relationships or conflict of interest to disclose:
Herschel W. Lawson, MD (Author, Accreditation Committee Chair)
Kerry O. Curtis, (ASSCCP Executive Director, Planner)
Chanise Reese-Queen (ASCCP Education and Meetings Director, Planner)
Carol Noonan (ASCCP Assistant Course Administrator, Planner)
For all CME certificate inquiries, please email email@example.com or by mail at the ASCCP National Office, 1530 Tilco Drive, Suite C, Frederick, MD 21704 or by phone at 301-733-3640